Document is current
Any future updates will be listed below
-
Authors
,
Ranna, Vinisha https://orcid.org/0000-0002-7075-3150
Cheng, Karis Kin Fong
Castillo, Daniel A.
Porcello, Lorraine
Vaddi, Anusha
Lalla, Rajesh V.
Bossi, Paolo
Elad, Sharon
- License Information
-
More Information
Article History
Received: 20 January 2019
Accepted: 22 May 2019
First Online: 8 July 2019
Compliance with ethical standards
:
: Employees of commercial entities were not eligible to serve on this MASCC Guidelines Panel. All authors completed a conflict of interest disclosure form and conflicts are disclosed in the guideline’s publications. The authors disclose no conflict of interest (VR, KC, LP, DC). PB has served an advisory role for Galera Therapeutics. SE reports no conflict in regard to mucositis, and consulting to Falk Pharma as the Medical Expert for a clinical trial about oral chronic graft versus host disease. RVL has served as a consultant for Colgate Oral Pharmaceuticals, Galera Therapeutics, Ingalfarma SA, Monopar Therapeutics, Mundipharma, and Sucampo Pharma; has received research support to his institution from Galera Therapeutics, Novartis, Oragenics, and Sucampo Pharma; and has received stock in Logic Biosciences.
